Skip to main content
Tech.euFundingExplorerBeta

StemX Bio

StemX Bio develops 3D human micro-tissues that replicate diseases more accurately than animal testing, enabling faster and safer drug development.

Total raised
€350k
€350,000
Funding rounds
1
Investors
1
distinct backers
Active since
2025-10
latest 2025-10

Funding by year

EUR raised per year

Signals

High confidence
Raise-next likelihood33
base rate 30% for Other
  • In typical raise window
  • Low backer re-investment

Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

1 rounds
DateStageAmountInvestors
2025-10-10Other€350kUNIIQView deal →

Investors

1

Related news

Similar companies

same sector or country